Systemic and skin toxicity in cercopithecus aethiops sabaeus monkeys treated during 26 weeks with a high intravenous dose of the anti-epidermal growth factor receptor monoclonal antibody nimotuzumab
Arteaga, Maria Elene, Nuris Ledon, Nuris, Casaco, Angel, Pardo, Balia, Garcia, Miriam, Boleda, Magela, Vina, Lisel, Orphee, Romy, Hernandez, Osvaldo, Gonzalez, Consuelo, Fuentes, Dasha, Rodriguez, Valia, Charro, Lidia, Baro, Farah, Macias, Amparo, Perez, Aylen, Morales, Yakelin, Subiros, Nelvys, Gonzalez, Barbara, Ramos, Mayra, Rodriquez, Leyanis, Ballester-Labrada, Alcides, Crombet, Tania
Published in Cancer biology & therapy (01.09.2007)
Published in Cancer biology & therapy (01.09.2007)
Get full text
Journal Article
Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma
Casaco, Angel, López, Gerardo, García, Iván, Arsenio Rodríguez, José, Fernández, Ramsés, Figueredo, Javier, Torres, Leonel, Perera Pintado, Alejandro, Batista, Juan, Leyva, René, Peña, Yamilé, Amador, Zaida, González, Addys, Estupiñan, Barbara, Coca, Marcos, Hernández, Abel, Puig, Miguel, Iglesias, Marbelia, Hernández, Astrid, Ramos, Mayra, Rodriquez, Leyanis, Suarez, Niurelkis
Published in Cancer biology & therapy (01.03.2008)
Published in Cancer biology & therapy (01.03.2008)
Get full text
Journal Article